CUV 1.42% $13.90 clinuvel pharmaceuticals limited

News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-112

  1. 22,423 Posts.
    lightbulb Created with Sketch. 487

    Media Release - Innovative drug launched for rare, isolating, “light intolerance” disorder in US
    https://hotcopper.com.au/data/attachments/2104/2104827-72fb1cc2152dd9a8346c2695db0199d9.jpg
    http://www.asx.com.au/asxpdf/20200416/pdf/44gzsq3x464fpr.pdf
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.